Bluebird Bio | 負債



Debt 変化する 日付
Agios Pharmaceuticals USD 0 0 2025-03
Alnylam Pharmaceuticals USD 1.03B 945K 2025-03
Amgen USD 57.38B 2.72B 2025-03
Arrowhead Research USD 388.24M 21.18M 2025-03
Biogen USD 6.3B 2M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
Incyte USD 37.12M 840K 2025-03
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
Moderna USD 745M 683M 2025-03
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
PTC Therapeutics USD 2.4B 17.29M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
Tectonic Therapeutic USD 876K 115K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Bluebird Bio 負債 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Jul 2025.